Research location
Mougins
France
Advertisement
Research activity in Mougins
FranceCureCurrent currently publishes aggregate city-level research activity for this location: 40 trials and 41 site observations.
The map is centered on registry-derived city coordinates. Circle size reflects published trial activity.
Below are current trials with one or more ClinicalTrials.gov site observations in this city. Results are paginated 50 per page, with recruiting studies shown first.
Trials with sites in Mougins
40 linked trials · page 1 of 1Treatment With Darolutamide +/- Radiation Therapy for Patients With a Castration Resistant Cancer and Metastases Detected by Functional ImagingNCT06276465 · 2024-10-07 · 1 site observation
RECRUITING
Evaluation of the Medical Benefit of Spa Therapy on Fibrosis After Radiotherapy for Breast Cancer or UADT (Upper Aerodigestive Tract) CancerNCT05874492 · 2024-01-29 · 1 site observation
RECRUITING
ADT +/- Darolutamide in de Novo Metastatic Prostate Cancer Patients With Vulnerable Functional Ability (PEACE6-Vulnerable)NCT04916613 · 2022-04-19 · 1 site observation
RECRUITING
Trial of Acetylsalicylic Acid and Atorvastatin in Patients With Castrate-resistant Prostate CancerNCT03819101 · 2019-06-06 · 1 site observation
RECRUITING
Streamlined Geriatric and Oncological Evaluation Based On IC TechnologyNCT05720910 · 2024-10-15 · 1 site observation
ACTIVE_NOT_RECRUITING
Observational Study in Patients With Previously Unresectable Malignant Pleural Mesothelioma Treated With Nivolumab and Ipilimumab (MESO-IMMUNE)NCT05308966 · 2022-05-03 · 1 site observation
COMPLETED
Study of the Impact of DPD Activity on the Efficacy of CapecitabineNCT04198727 · 2020-07-20 · 1 site observation
ACTIVE_NOT_RECRUITING
Prostate-cancer Treatment Using Stereotactic Radiotherapy for Oligometastases Ablation in Hormone-sensitive PatientsNCT04115007 · 2020-06-23 · 1 site observation
ACTIVE_NOT_RECRUITING
Radiotherapy Omission in Low Risk Ductal in Situ Carcinoma BreastNCT03878342 · 2019-05-10 · 1 site observation
ACTIVE_NOT_RECRUITING
Comparison of Intermittent Androgen Deprivation Therapy With or Without Irradiation Recovery in Prostate Cancer PatientsNCT03630666 · 2018-12-04 · 1 site observation
ACTIVE_NOT_RECRUITING
PD-1 Inhibitor and Chemotherapy With Concurrent Irradiation at Varied Tumour Sites in Advanced Non-small Cell Lung CancerNCT03774732 · 2018-01-24 · 2 site observations
ACTIVE_NOT_RECRUITING
Randomized, Open Label, Clinical Study of the Targeted Therapy, Palbociclib, to Treat Metastatic Breast CancerNCT02947685 · 2017-06-21 · 1 site observation
ACTIVE_NOT_RECRUITING
Addition of Aromatase at the Navelbine in Pretreated Metastatic Breast Cancer.NCT02585388 · 2015-10-23 · 1 site observation
TERMINATED
Evaluating the Effectiveness of Neupro® (Rotigotine) and L-dopa Combination Therapy in Patients With Parkinson's DiseaseNCT02227355 · 2014-09-01 · 1 site observation
COMPLETED
A Phase III Study for Patients With Metastatic Hormone-naïve Prostate CancerNCT01957436 · 2013-11-13 · 1 site observation
ACTIVE_NOT_RECRUITING
Trastuzumab & Pertuzumab Followed by T-DM1 in MBCNCT01835236 · 2013-03-03 · 1 site observation
COMPLETED
A Study of Pertuzumab in Combination With Trastuzumab (Herceptin) and a Taxane in First-Line Treatment in Participants With Human Epidermal Growth Factor 2 (HER2)-Positive Advanced Breast CancerNCT01572038 · 2012-06-01 · 1 site observation
COMPLETED
A Safety and Tolerability Study of Assisted and Self-Administered Subcutaneous (SC) Herceptin (Trastuzumab) as Adjuvant Therapy in Early Human Epidermal Growth Factor Receptor 2 (HER2)-Positive Breast CancerNCT01566721 · 2012-05-17 · 1 site observation
COMPLETED
Medico-economic Interest of Taking Into Account Circulating Tumor Cells (CTC) to Determine the Kind of First Line Treatment for Metastatic, Hormone-receptors Positive, Breast CancersNCT01710605 · 2012-02-01 · 1 site observation
UNKNOWN
An Observational Study of Avastin (Bevacizumab) in Patients With HER2-metastatic or Locally Advanced Breast CancerNCT01461044 · 2011-09-01 · 1 site observation
COMPLETED
An Observational Study of Patients With HER2-Positive Metastatic or Locally Advanced Breast Cancer Treated With Herceptin (Trastuzumab) in 1st Line and Without Progression For 3 YearsNCT01480674 · 2011-03-28 · 1 site observation
COMPLETED
Treatment Decision Impact of OncotypeDX™ in HR+, N- Breast Cancer PatientsNCT01446185 · 2011-01-01 · 1 site observation
COMPLETED
Bevacizumab + Paclitaxel + Capecitabine in Triple Negative Metastatic Breast CancerNCT01069796 · 2010-04-01 · 1 site observation
TERMINATED
Radiation Therapy in Treating Patients Receiving Hormone Therapy for Prostate Cancer (GETUG-AFU 18)NCT00967863 · 2008-10-01 · 1 site observation
ACTIVE_NOT_RECRUITING
TraStuzumAb-Radiotherapy : Impact on the Cerebral PreventionNCT01613482 · 2008-01-01 · 1 site observation
TERMINATED
BEATRICE Study: A Study of Bevacizumab (Avastin) Adjuvant Therapy in Triple Negative Breast CancerNCT00528567 · 2007-12-01 · 1 site observation
COMPLETED
Comparison of Biphasic Insulin Aspart 30 Versus Insulin Glargine Both in Combination With Metformin and Glimepiride in Subjects With Type 2 DiabetesNCT00469092 · 2007-05-01 · 1 site observation
COMPLETED
Efficacy and Safety of Inhaled Pre-prandial Human Insulin in Type 2 DiabetesNCT00348712 · 2006-10-30 · 1 site observation
TERMINATED
A Study of Avastin (Bevacizumab) Plus Taxane-Based Therapy in Patients With Locally Recurrent or Metastatic Breast Cancer.NCT00448591 · 2006-09-01 · 1 site observation
COMPLETED
Effect of Liraglutide on Blood Glucose Control in Subjects With Type 2 DiabetesNCT00318422 · 2006-05-01 · 1 site observation
COMPLETED
Trastuzumab for 6 Months or 1 Year in Treating Women With Nonmetastatic Breast Cancer That Can Be Removed By SurgeryNCT00381901 · 2006-05-01 · 1 site observation
COMPLETED
Comparison of Biphasic Insulin Aspart 70/30, 50/50, and 30/70 in Subjects With Type 2 DiabetesNCT00184574 · 2005-04-01 · 1 site observation
COMPLETED
Effect of Liraglutide on Blood Glucose Control in Subjects With Type 2 DiabetesNCT00154401 · 2005-01-01 · 1 site observation
COMPLETED
Safety and Efficacy of Insulin Detemir Plus Insulin Aspart Against Insulin Glargine Plus Insulin Aspart as Mealtime Insulin in Type 1 DiabetesNCT00095082 · 2004-09-01 · 1 site observation
COMPLETED
The Use of Zoledronic Acid to Prevent Cancer-treatment Bone Loss in Post-menopausal Women Receiving Adjuvant Letrozole for Breast CancerNCT00171314 · 2004-03-01 · 1 site observation
COMPLETED
Phase II Metastatic ER+/PgR+ Nolvadex +/- Iressa StudyNCT00229697 · 2003-10-01 · 1 site observation
COMPLETED
Safety and Efficacy of Insulin Detemir in Combination With OAD in Type 2 DiabetesNCT00604396 · 2003-03-01 · 1 site observation
COMPLETED
Combination Chemotherapy in Treating Women With Stage I Breast CancerNCT00055679 · 2002-08-01 · 1 site observation
COMPLETED
Comparison of Insulin Detemir Plus Insulin Aspart With Insulin NPH Plus Human Soluble Insulin in Subjects With Type 1 DiabetesNCT01486940 · 2002-03-01 · 1 site observation
COMPLETED
Exemestane As Treatment In Adjuvant For Post-Menopausal Patients With Non-Metastatic Breast CancerNCT00279448 · 2002-01-01 · 1 site observation
COMPLETED
Advertisement
Registry-derived research relationships: ClinicalTrials.gov. Raw condition and intervention labels remain distinct from canonical MONDO/RxNorm entities unless separately normalized.